Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Geron (GERN) Research & Development (2016 - 2025)

Geron's Research & Development history spans 16 years, with the latest figure at $13.5 million for Q4 2025.

  • For Q4 2025, Research & Development fell 42.18% year-over-year to $13.5 million; the TTM value through Dec 2025 reached $71.4 million, down 31.14%, while the annual FY2025 figure was $71.4 million, 31.14% down from the prior year.
  • Research & Development for Q4 2025 was $13.5 million at Geron, down from $21.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $35.5 million in Q2 2023 and bottomed at $13.5 million in Q4 2025.
  • The 5-year median for Research & Development is $22.8 million (2022), against an average of $24.1 million.
  • The largest annual shift saw Research & Development surged 102.28% in 2021 before it tumbled 48.67% in 2025.
  • A 5-year view of Research & Development shows it stood at $24.2 million in 2021, then increased by 16.81% to $28.2 million in 2022, then rose by 16.66% to $32.9 million in 2023, then fell by 28.8% to $23.4 million in 2024, then crashed by 42.18% to $13.5 million in 2025.
  • Per Business Quant, the three most recent readings for GERN's Research & Development are $13.5 million (Q4 2025), $21.1 million (Q3 2025), and $21.7 million (Q2 2025).